Autoinduction of phase I and phase II metabolism of artemisinin in rats

References

• Ashton M, Hai TN, Sy ND, Huong DX, Van Huong N, Niêu NT, Công LD. (1998). Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metab Dispos 26:25–27.
   PubMed Web of Science ®Google Scholar
• Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV, Petzold MG, Simonsson US, Ashton M. (2007). Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. Fundam Clin Pharmacol 21:307–316.
   PubMed Web of Science ®Google Scholar
• Asimus S, Gordi T. (2007). Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction model. Br J Clin Pharmacol 63:758–762.
   PubMedGoogle Scholar
• Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M. (2005). Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 67:1954–1965.
   PubMed Web of Science ®Google Scholar
• Capela R, Cabal GG, Rosenthal PJ, Gut J, Mota MM, Moreira R, Lopes F, Prudêncio M. (2011). Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy. Antimicrob Agents Chemother 55:4698–4706.
   PubMed Web of Science ®Google Scholar
• Codd A, Teuscher F, Kyle DE, Cheng Q, Gatton ML. (2011). Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure. Malar J 10:56.
   PubMedGoogle Scholar
• Court MH. (2010). Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42:209–224.
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, von Seidlein L. (2010). Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 8:272–280.
   PubMed Web of Science ®Google Scholar
• Elsherbiny DA, Asimus SA, Karlsson MO, Ashton M, Simonsson US. (2008). A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens. J Pharmacokinet Pharmacodyn 35:203–217.
   PubMed Web of Science ®Google Scholar
• Falade CO, Ogundele AO, Yusuf BO, Ademowo OG, Ladipo SM. (2008). High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Trop Med Int Health 13:635–643.
   PubMed Web of Science ®Google Scholar
• Giao PT, Binh TQ, Kager PA, Long HP, Van Thang N, Van Nam N, de Vries PJ. (2001). Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg 65:690–695.
   PubMedGoogle Scholar
• Gordi T, Huong DX, Hai TN, Nieu NT, Ashton M. (2002). Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens. Antimicrob Agents Chemother 46:1026–1031.
   PubMed Web of Science ®Google Scholar
• Gupta S, Svensson US, Ashton M. (2001). In vitro evidence for auto-induction of artemisinin metabolism in the rat. Eur J Drug Metab Pharmacokinet 26:173–178.
   PubMedGoogle Scholar
• Hien TT, Hanpithakpong W, Truong NT, Dung NT, Toi PV, Farrar J, Lindegardh N, Tarning J, Ashton M. (2011). Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study. Clin Ther 33:644–654.
   PubMed Web of Science ®Google Scholar
• Komura H, Iwaki M. (2011). In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. Drug Metab Rev 43:476–498.
   PubMed Web of Science ®Google Scholar
• Li XQ, Björkman A, Andersson TB, Gustafsson LL, Masimirembwa CM. (2003). Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 59:429–442.
   PubMed Web of Science ®Google Scholar
• Liu T, Du F, Wan Y, Zhu F, Xing J. (2011). Rapid identification of phase I and II metabolites of artemisinin antimalarials using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange technique. J Mass Spectrom 46:725–733.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–894.
   PubMed Web of Science ®Google Scholar
• Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. (2001). Possible modes of action of the artemisinin-type compounds. Trends Parasitol 17:122–126.
   PubMed Web of Science ®Google Scholar
• Simonsson US, Jansson B, Hai TN, Huong DX, Tybring G, Ashton M. (2003). Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 74:32–43.
   PubMed Web of Science ®Google Scholar
• Song J, Socheat D, Tan B, Seila S, Xu Y, Ou F, Sokunthea S, Sophorn L, Zhou C, Deng C, Wang Q, Li G. (2011). Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area. Malar J 10:231.
   PubMed Web of Science ®Google Scholar
• Svensson US, Ashton M. (1999). Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol 48:528–535.
   PubMed Web of Science ®Google Scholar
• Svensson US, Mäki-Jouppila M, Hoffmann KJ, Ashton M. (2003). Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling. Biopharm Drug Dispos 24:71–85.
   PubMed Web of Science ®Google Scholar
• White NJ. (2004). Antimalarial drug resistance. J Clin Invest 113:1084–1092.
   PubMed Web of Science ®Google Scholar
• Zhu DY, Huang BS, Chen ZL, Yin ML, Yang YM, Dai ML, Wang BD, Huang ZH. (1983). [Isolation and identification of the metabolite of artemisinine in human]. Zhongguo Yao Li Xue Bao 4:194–197.
   PubMedGoogle Scholar